{"id":481547,"title":"Qualifying notice amendment for Opdivo - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:56:24.581000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-amendment-opdivo-259148.html?wbdisable=true","snippet":"Qualifying notice amendment for Opdivo Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney's Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e177442 Control #: 259148 [employee's name removed] [employee's title removed]…","rawSnapshotUrl":"/api/snapshots/raw/481547","browseUrl":"https://replay.healtharchive.ca/job-6/20260106165624/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-amendment-opdivo-259148.html?wbdisable=true#ha_snapshot=481547","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}